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Abstract Using the gene targeting technique, we have generated 
a new mouse model of congenital muscular dystrophy (CMD), a 
null mutant for the laminin oc2 chain. These homozygous mice, 
designated dy3Kldy3K, are characterized by growth retardation 
and severe muscular dystrophic symptoms and die by 5 weeks of 
age. Light microscopy revealed that muscle fiber degeneration in 
these mice begins no later than postnatal day 9. In degenerating 
muscles, considerable amounts of TUNEL positive nuclei were 
detected as well as D N A laddering, suggesting increased 
apoptotic cell death was involved in the process of muscle fiber 
degeneration. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The laminin oc2 chain is a tissue-restricted heavy chain com-
ponent of laminin, a basement membrane-associated molecule 
expressed mainly in striated muscle, Schwann cells, and troph-
oblast [1,2]. Specific mutat ions in the gene that encodes the 
laminin a 2 chain cause a merosin (laminin 2)-deficient con-
genital muscular dystrophy (CMD) [3], and autosomal reces-
sive muscle disorder. Researchers have identified two animal 
models of this disease, dyldy [4-7] and dy2Jldy2J [8,9] mice. 
These models have provided valuable information about the 
importance of laminin a 2 chain in C M D , but are limited 
because they permit the expression of the chain, either in a 
greatly reduced or in a truncated form. This paper explains 
the use of homologous recombination to generate a new 
C M D mouse model, a null mutan t for the laminin oi2 chain. 
2. Materials and methods 
2.1. Embryonic stem (ES) cell selection 
A 5.4 kbp mouse genomic DNA fragment containing a portion of 
the Lama2 gene was isolated from a 129/Sv mouse genomic library 
(Stratagene) and subcloned into Bluescript II SK+ vector (Strata-
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gene). A pMClneo polyA+ cassette (Stratagene) was then inserted 
into an exon (385-627, +1 denotes the translation start site, amino 
acids 128-209) [10] followed by the insertion of the MC1TK gene into 
the 3'-end of the genomic fragment as shown in Fig. la. This targeting 
vector was linearized by cleaving it at its unique NotI site, then elec-
troporated into E14 ES cells [11]. Positive clones were selected by 
challenging the ES cultures with G418 (0.3 mg/ml) and gancyclovir 
(2 μΜ) as previously described [11] and, subsequently, screening the 
surviving cultures using PCR (primer 1 (Lama2 intron sequence): 5'-
CTT TCA GAT TGC ATT GCA AGC-3', primer 2 (neo cassette 
sequence): 5'-TCG TTT GTT CGG ATC CGT CG-3'). The results 
of the PCR reactions were confirmed by a Southern blot using the 
probe shown in Fig. la. The injection of positive ES clones into 
blastocysts was also carried out as already described [11]. 
2.2. Indirect immunofluorescence 
Rat monoclonal antibodies against the mouse laminin a2 chain, 
4H8-2 [12], and against the mouse laminin a l chain, 198 [13], were 
provided by Dr. L. Sorokin. A rat monoclonal antibody against lam-
inin γΐ (Β2) chain was obtained from Chemicon Int. Inc. (Temecula, 
CA). Cryostat was used to prepare 6-8 μιη cryosections for hematox-
ylin-eosin staining or indirect immunofluorescence. After incubation 
with primary antibodies (1:10 dilution for monoclonal antibodies), 
the sections were washed in PBS, then incubated with rhodamine-
labeled secondary antibodies (1:200 dilution, Organon Teknika 
Corp., Durham, NC) to reveal the primary antibodies. 
2.3. Western blot 
Muscle cryosections were boiled for 5 min in a buffer containing 
15% sodium dodecyl sulfate (SDS), 70 mM Tris-HCl (pH 6.7), 10 mM 
EDTA, and 5% ß-mercaptoethanol. After centrifugation, the protein 
content of the supernatants was estimated using the BioRad protein 
assay system. The muscle extracts were then separated on a 6% SDS-
polyacrylamide gel, and electrotransferred to Immobilon membranes 
(Millipore). 2D9 [14] was used at a 1:10 dilution. Antibody binding 
was revealed by horseradish peroxidase-linked sheep anti-mouse Ig 
and the enhanced chemiluminescence method (Amersham). 
2.4. Transmission electron microscopy 
Specimens of anterior tibial muscles from 11-day-old wild-type and 
dy3KldySK mice were fixed in 2.5% glutaraldehyde, rinsed in 0.1 M 
cacodylate buffer (pH 7.2), postfixed in 1% OSO4 in cacodylate buffer, 
then embedded in resin. Ultra thin sections were stained with uranyl 
acetate and lead citrate, then examined with a Hitachi H-600 electron 
microscope. 
2.5. DNA laddering assays 
Genomic DNA was extracted from calf muscles using lysis buffer 
(150 μg/ml proteinase K, 1 mg/ml pronase E, 50 mM Tris-HCl pH 
8.0, 0.1 M NaCl, 20 mM EDTA and 1% SDS). After treatment with 
RNase, 5 μg of genomic DNA was labeled with [a-32P]dCTP using 
terminal transferase [15] (Boehringer Mannheim), resolved on a 2.0% 
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agarose gel, transferred to a nylon membrane (Hybond-N+ 
sham), and, finally, visualized using autoradiography. 
Amer-
2.6. TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP 
nick end-labeling) technique [16] 
Cryosections of calf muscles (10 μιη) were fixed with 10% neutral 
buffered formalin for 10 min at room temperature. The sections were 
then post-fixed in ethanol:acetic acid (2:1) for 5 min at —20°C, la-
beled with DIG-conjugated dUTP, reacted with a peroxidase-conju-
gated anti-DIG antibody (Oncor), and then stained with amino-9-
ethylcarbazole as substrate to produce a red reaction product 
(Zymed), and counterstained with methyl green. The numbers of TU-
NEL positive nuclei were counted on photographs of 10-20 different 
sections. With a stage micrometer, we estimated the average number 
of TUNEL positive nuclei (nuclei/mm3) in each sample. 
3. Results and discussion 
To construct a gene-targeting vector for disruption of the 
mouse laminin cc2 chain (Lamal) gene, a genomic fragment 
that includes an exon which encodes a part of domain VI of 
the laminin a2 chain [10] was subcloned into the Bluescript II 
SK+ vector. A neomycin resistance cassette (neo) was then 
inserted into the exon in reverse orientation (Fig. la). For 
negative selection, the HSV thymidine kinase (tk) gene was 
ligated to the new construct. The resulting vector was linear-
ized and transfected into ES cells (E14) by electroporation. 
Gancyclovir-G418 doubly resistant colonies were then selected 
as already described [11]. The homologous recombination was 
first identified by PCR, then confirmed by Southern blotting 
(data not shown). Four independent ES clones were injected 
into C57BL/6 blastocysts to obtain germ line chimeras [11]. 
The male chimeric mice were then allowed to breed with fe-
male ICR, BALB/c and 129/Sv mice resulting in the trans-
mission of the mutated alíeles of two independent ES clones 
to the offspring. The presence of the targeted alíele in the 
offspring was detected by Southern blot analysis (Fig. la,b). 
Heterozygotes were phenotypically normal and were used to 
breed homozygous mice. The homozygotes appeared at the 
frequency predicted according to Mendelian genetics. New-
born homozygous mice were indistinguishable from their het-
erozygous or wild-type littermates at birth, while by postnatal 
Fig. 1. Generation of the laminin a2 chain (Lama2) gene targeted mice using homologous recombination, a: Strategy of the targeted disruption 
of the Lama2 gene in ES cells, b: Southern blot of genomic DNA isolated from each pup of a litter born to heterozygous (+/—) parents. Ge-
nomic DNA (10 μg) was digested with Spel and hybridized with the DNA probe illustrated in a part of a. The wild-type and targeted loci gen-
erate 4.9 kb and 6.0 kb Spel fragments, respectively. A homozygote (—/—) is shown in lane 1. Heterozygotes' DNA (+/—) are in lanes 3, 4, 7 
and 9, and their wild-type littermates' (+/+) are in lanes 2, 5, 6 and 8. c: Photograph of wild-type (right) and mutant (left) littermates on post-
natal day 28 (P28). d: Growth of mutant mice and their wild-type littermates. The body weight of wild-type (34 mice) and homozygous mutant 
mice (31 mice) is plotted. Heterozygotes grow at the same rate as their wild-type littermates. 
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Fig. 2. The Lama2 gene targeted mice are null mutants, a: Western 
blot using a monoclonal antibody against the laminin a2 chain, 
2D9 [14]. Extraction lysates from wild-type calf muscles (WT) are 
loaded in lanes 1-3, and samples from dy3KldySK muscle are in 
lanes 4-6. The amount of protein used is: 5 μg in lanes 1 and 4, 10 
μg in lanes 2 and 5, and 20 μg in lanes 3 and 6. Extracts from car-
diac muscle were also analyzed (lanes 7, 8). The asterisk indicates a 
non-specific band, b: No laminin cc2 chain immunopositive fibers in 
mutant calf and cardiac muscles. Acetone-fixed frozen sections of 
wild-type (WT) and dySKldySK calf muscles were stained with a rat 
monoclonal antibody, 4H8-2 [12], against the mouse laminin rx2 
chain. 
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day 14 (P14), their retarded growth became apparent; from 
this point, their body size remained comparatively small for 
the remainder of their lives (Fig. lc,d). By P21, these mice 
displayed overt dystrophic symptoms, such as waddling gait 
and twitching, characteristic of dyldy dystrophic mice [4]. 
However, unlike previously studied dystrophic mice, these 
mice succumbed to undetermined causes by 5 weeks of age. 
In comparison, the average life span of dyldy mice has been 
reported to be 5-6 months [17]. 
Immunoblotting with the mouse anti-laminin oc2 chain 
monoclonal antibody, 2D9 [14], which binds the G2-G3 re-
gion of the G domain, failed to detect either the 300 kDa C-
terminal fragment or truncated laminin oc2 chain in homozy-
gous skeletal or cardiac muscle (Fig. 2a). Indirect immuno-
staining with the rat monoclonal antibody, 4H8-2 [12], which 
also recognizes the 300 kDa portion of the protein, confirmed 
the absence of the laminin a2 chain in both muscles (Fig. 2b). 
Dystrophic dyldy mice [4], carrying an unidentified mutation 
in the Lama2 gene [5-7], express low but detectable levels of 
the laminin oc2 chain while dy2Jldy2J mice express a truncated 
form of the chain [8,9]. The homozygous mice described in 
this paper are null mutants and they have been designated 
dySKldy3K. Since there are no significant differences in pheno-
typic expression in dySKldySK mice that have different genetic 
backgrounds, the results reported here are limited to mice of 
the ICR background. 
Before P9, dy3Kldy3K skeletal muscles are comparable to 
those of their wild-type littermates when examined using hem-
atoxylin-eosin staining. Scattered degenerative fibers began to 
appear at P9 (see Fig. 3a), and, at P l l , numerous degenerated 
muscle fibers along with extensive infiltrates and evidence of 
phagocytosis could been seen (see Fig. 3a). At P13, groups of 
centrally nucleated small-caliber muscle fibers appeared, re-
vealing the process of active regeneration (see Fig. 3a). The 
changes in skeletal muscle progressed focally, rather than dif-
fusely, and were more prominent in calf muscles than in thigh 
muscles. In spite of active regeneration in the early neonatal 
stage, degeneration continued and resulted in the variability of 
fiber size and proliferation of endomysial connective tissue 
observed at P21 and P28 (not shown). 
To determine the molecular basis of the muscle fiber degen-
eration, we analyzed the influence of laminin oc2 chain deple-
tion on the basal lamina of skeletal muscle. The laminin γΐ 
chain (Fig. 3b), collagen type IV and perlecan (not shown), 
other constituents of basal lamina, were clearly immuno-
stained around the muscle fibers of 4 week old dySK/dySK 
mice, although the staining was more sparse than that of their 
wild-type littermates. The same results were obtained using P3 
and P13 mutant muscle (not shown). Laminin a l , which lo-
calizes at the neuromuscular junctions of normal muscle, was 
slightly up-regulated in dy3K/dy3K mutant muscles, when im-
munostained with a rat monoclonal antibody, 198 [13] (see 
Fig. 3b). Dystrophin, a muscle-specific membrane-related cy-
toskeletal protein, was expressed at an equivalent level in both 
control and mutant muscles (not shown). At the neuromus-
cular junction, neuronal cell adhesion molecule and the dys-
trophin-related protein, utrophin, stained normal proportions 
(data not shown). Although it seemed that most constituents 
of the basal lamina were present, there was a nearly complete 
absence of the basal lamina around the muscle fiber and 
around the Schwann cells of peripheral nerves in electron 
microscopic examination (Fig. 4). This defect in the basal 
Fig. 3. In mutant mice, muscle degeneration appeared at an early 
neonatal period, a: Muscle fiber degeneration and regeneration oc-
curred in the calf muscles of mutant mice. These are representative 
sections from postnatal day 9 (P9), Pll and P13. Hematoxylin-eosin 
staining, X200. b: Cryosections of skeletal muscles from 3 week old 
mice were stained with rat monoclonal antibodies against the lami-
nin al chain, 198 [13], and the laminin γΐ chain (Chemicon). Mag-
nification: X400. 
lamina was also discovered in dyldy [5,6] mice but was thinner 
and discontinuous. 
Recently, it was reported that the lack of the laminin oc2 
chain results in apoptotic cell death in myogenic cells in vitro, 
where the laminin a2 chain appears to promote myotube 
stability by preventing apoptosis [18]. To determine whether 
the absence of the laminin oc2 chain in dy3K/dy3K mice causes 
apoptotic muscle cell death, we used TUNEL [16] to search 
for apoptosis-associated DNA strand breaks in situ (Fig. 5). 
In the degenerating muscle of dySKldy3K mice (Pll) , there 
were a markedly higher number of TUNEL positive nuclei, 
compared to the muscles of their wild-type littermates. The 
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TUNEL positive cells were visible at the surface of muscle 
fibers that had no apparent degeneration (Fig. 5a) and those 
existing in areas with extensive infiltrates (Fig. 5a). We then 
extracted genomic DNA from the affected muscle and car-
ried out DNA laddering assays, using 3'-end labeling with 
[a-32P]dCTP. Consistent with the TUNEL assay results, ge-
nomic DNA from degenerating muscle showed DNA ladder-
ing in multiples of about 180 bp, indicating internucleosomal 
fragmentation (Fig. 5b). 
The TUNEL technique was also used to determine the role 
of apoptosis during dy3Kldy3K muscle development before 
PI 1. The number of TUNEL positive nuclei in the muscles 
of null mutant mice at P3, P7 and P9 was not appreciably 
different from that in wild-type muscles (Fig. 5c). It is possible 
that early neonatal mutant muscles contain trophic factors 
that prevent apoptotic cell death in neonatal myofibers lack-
ing the laminin a2 chain. These effects are less important at 
PI 1, when degeneration is most prominent and TUNEL pos-
itive nuclei increase to as much as 1% of the total number of 
nuclei (Fig. 5c). At this time, necrotic changes and inflamma-
tory infiltrates also become apparent. Dystrophie dySKldySK 
mice experience both apoptotic and necrotic cell death in their 
degenerating muscles. Recent studies have reported an in-
crease in programmed cell death in dystrophin deficient mdx 
mice [19-22], though the mechanism has not yet been deter-
mined. Likewise, the trigger of apoptotic cell death in dy3Kl 
dy3K mutant myofibers is not clear; the role of apoptosis in 
muscle degeneration remains to be determined. 
Fig. 4. Transmission electron microscopy of skeletal muscle. The 
basal lamina, clearly present along the sarcolemma in wild-type 
mouse (a), was almost completely absent in all muscle fibers of the 
mutant mouse at PI 1 (b). The arrowheads point to the basal lamina 
of muscle fibers, c: The basal lamina of Schwann cells in intramus-
cular nerve bundles was also absent (indicated by arrows). Magnifi-
cation: X 50 000. 
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Fig. 5. Detection of apoptosis-associated DNA strand breaks in mu-
tant skeletal muscles, a: In situ detection of DNA fragmentation in 
mutant {dy3Kldy3K) muscles at PI 1, using the TUNEL technique 
[16]. Apoptotic nuclei (arrows) in Pll mutant muscle were labelled 
with a peroxidase-conjugated anti-DIG antibody using 3-amino-9-
ethylcarbazole (red). Magnification: X400. b: DNA laddering as-
says of genomic DNA (5 μg/lane) from wild-type (lane 1) and mu-
tant (lane 2) muscles. The migration positions of a 100 bp DNA 
ladder are indicated, c: Density of TdT-dUTP labeled apoptotic my-
onuclei in mutant and wild-type muscles of different ages. The esti-
mated average densities (nuclei/mm3) were plotted with standard er-
ror bars. 
Laminin a2 chain mRNA [10,23] and protein are expressed 
in several organs other than striated muscles, including the 
central nervous system [24], thyroid gland, thymus [25], kid-
ney, testis, skin [26] and digestive tract [27]. Since dy3Kldy3K 
mice have no laminin a2 chain, they provide an excellent 
model to analyze the biological functions of laminin a2 chain 
in these organs. 
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